Cardlytics Inc. (NASDAQ:CDLX) went down by -3.13% from its latest closing price compared to the recent 1-year high of $161.47. The company’s stock price has collected -3.40% of loss in the last five trading sessions. Press Release reported 12 hours ago that Cardlytics Announces Pricing of Public Offering of Common Stock
Is It Worth Investing in Cardlytics Inc. (NASDAQ :CDLX) Right Now?
Opinions of the stock are interesting as 1 analysts out of 6 who provided ratings for Cardlytics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $138.75, which is -$51.2 below the current price. CDLX currently public float of 25.11M and currently shorts hold a 12.98% ratio of that float. Today, the average trading volume of CDLX was 403.59K shares.
CDLX’s Market Performance
CDLX stocks went down by -3.40% for the week, with a monthly jump of 9.59% and a quarterly performance of 12.29%, while its annual performance rate touched 56.30%. The volatility ratio for the week stands at 9.96% while the volatility levels for the past 30 days are set at 6.49% for Cardlytics Inc.. The simple moving average for the period of the last 20 days is -10.30% for CDLX stocks with a simple moving average of 35.03% for the last 200 days.
Analysts’ Opinion of CDLX
Wells Fargo, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $80. The rating they have provided for CDLX stocks is “Equal Weight” according to the report published on August 28th, 2020.
CDLX Trading at -5.74% from the 50-Day Moving Average
After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.61% of loss for the given period.
Volatility was left at 6.49%, however, over the last 30 days, the volatility rate increased by 9.96%, as shares sank -2.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.32% lower at present.
During the last 5 trading sessions, CDLX fell by -6.01%, which changed the moving average for the period of 200-days by +138.35% in comparison to the 20-day moving average, which settled at $144.53. In addition, Cardlytics Inc. saw -6.14% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at CDLX starting from Grimes Scott D., who sale 2,000 shares at the price of $137.44 back on Feb 23. After this action, Grimes Scott D. now owns 238,908 shares of Cardlytics Inc., valued at $274,889 using the latest closing price.
Grimes Scott D., the Director of Cardlytics Inc., sale 2,000 shares at $157.21 during a trade that took place back on Feb 16, which means that Grimes Scott D. is holding 93,112 shares at $314,413 based on the most recent closing price.
Stock Fundamentals for CDLX
Current profitability levels for the company are sitting at:
- -8.23 for the present operating margin
- +41.73 for the gross margin
The net margin for Cardlytics Inc. stands at -8.15. The total capital return value is set at -14.32, while invested capital returns managed to touch -14.17. Equity return is now at value -32.20, with -18.00 for asset returns.
Based on Cardlytics Inc. (CDLX), the company’s capital structure generated 0.03 points at debt to equity in total, while total debt to capital is 0.03. Total debt to assets is 0.02, with long-term debt to equity ratio resting at 0.01. Finally, the long-term debt to capital ratio is 0.01.
When we switch over and look at the enterprise to sales, we see a ratio of 6.60, with the company’s debt to enterprise value settled at 0.00. The receivables turnover for the company is 2.88 and the total asset turnover is 1.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.50.